News Conference News ACC 2025 Tight Fluid Restriction Not Needed in Chronic HF Patients: FRESH-UP Michael O'Riordan April 01, 2025
News Conference News ACC 2025 By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE Michael O'Riordan March 31, 2025
News Conference News ACC 2024 IMPROVE-HCM: Ninerafaxstat May Fill a Niche in Nonobstructive HCM Caitlin E. Cox April 15, 2024
News Conference News ACC 2024 Compared With Usual Care, Incorporating Inclisiran Early Cuts LDL Yael L. Maxwell April 09, 2024
News Conference News ACC 2023 CRP More Predictive of Future Events Than LDL in Statin-Treated Patients Caitlin E. Cox March 14, 2023
News Conference News ACC 2023 How Dapagliflozin Works in HFpEF: Some Clues From CAMEO-DAPA Todd Neale March 09, 2023
News Conference News ACC 2022 No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3 Michael O'Riordan April 13, 2022
News Conference News ACC 2022 QoL Gains Within 15 Days in Acute HF With Empagliflozin: EMPULSE Analysis L.A. McKeown April 07, 2022
News Conference News ACC 2022 In Vaccine Era, Deaths Drop Sharply in STEMI Patients With COVID-19 Caitlin E. Cox April 04, 2022
News Conference News ACC 2021 Cooling OHCA Patients to 31°C Not Superior to 34°C: CAPITAL-CHILL Caitlin E. Cox May 26, 2021
News Conference News ACC 2021 REHAB-HF: Tailored Cardiac Rehab Promotes Physical Function After Hospital Stay Caitlin E. Cox May 16, 2021
News Conference News ACC 2021 Dapagliflozin No Help, but No Harm, in Hospitalized COVID-19 Patients Shelley Wood May 16, 2021
News Conference News ACC 2021 ‘Enormous’ QoL Improvements With Mavacamten in HCM Shelley Wood May 15, 2021
News Conference News ACC 2021 STEMI App Lowers Time to Treatment Across Regional Health System Yael L. Maxwell May 07, 2021
News Conference News ACC 2021 Poorer Neighborhoods Pose Risks for Black Patients After Acute MI L.A. McKeown May 05, 2021
News Daily News ACC 2020 Better QoL After MitraClip Plus Fewer Deaths, HF Hospitalizations: COAPT Shelley Wood March 17, 2020
News Conference News ACC 2018 Canakinumab Falls Short of Halting Progression to Diabetes in Patients at Risk: CANTOS Michael O'Riordan March 12, 2018
News Conference News ACC 2018 iFR Cheaper Than FFR Over Trajectory of 1 Year: DEFINE-FLAIR Analysis Caitlin E. Cox March 10, 2018
News Conference News ACC 2017 SPIRE 1 and 2: Support for PCSK9 Inhibition but Not Bococizumab Yael L. Maxwell March 17, 2017